WGS CIK: 1818331

GeneDx Holdings Corp.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−190
FY22:
−319
FY23:
−180
FY24:
−28.5
FY25:
33.3
Change from FY21 to FY25
millions USD
FY21:
−20.8
FY22:
−141
FY23:
−43.7
FY24:
−30.1
FY25:
−61.5
Change from FY21 to FY25
millions USD
FY21:
494
FY22:
197
FY23:
186
FY24:
44.2
FY25:
48.0
millions USD
FY21:
283
FY22:
−263
FY23:
−37.6
FY24:
−14.5
FY25:
19.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−200
FY22:
−326
FY23:
−185
FY24:
−34.0
FY25:
14.3

All amounts in millions USD Data source:SEC EDGAR